Latest Articles
31. 05. 2022
List of reimbursed medicinal products valid as of 1.6.2022
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
24. 05. 2022
Scientific Advice on Marketing Authorisation Issues
Upon request, the Marketing Authorisation Section of the State Institute for Drug Control (hereinafter referred to as the “Institute”) provides Scientific Advice concerning...
29. 04. 2022
List of reimbursed medicinal products valid as of 1.5.2022
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
cz
